Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
AUA Partners with Pfizer to Launch $1.5 Million RFP to Advance Care for Patients with Advanced Prostate Cancer
10:46am, Friday, 03'rd Jan 2025
BALTIMORE, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The American Urological Association Education and Research, Inc. (AUAER) is proud to announce a collaboration with Pfizer Medical Grants & Partnerships (GM
Pfizer Rises 5.6% in a Month: How Should You Play the Stock?
10:01am, Friday, 03'rd Jan 2025
Pfizer's PFE stock has risen 5.6% in the past month. This was due to the company's encouraging guidance for 2025 issued in mid-December 2025.
3 Ultra-High-Yield Dividend Stocks That Are Screaming Buys in 2025
05:21am, Friday, 03'rd Jan 2025
When the closing bell rang on Dec. 31, the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite had delivered respective returns of 13%, 23%, and 29% in 2024. The icing on the cake is that all
10 Magnificent Stocks That Can Make You Richer in 2025
05:06am, Friday, 03'rd Jan 2025
For a second straight year, investors have been given every reason to smile. As of this writing, with one trading day left in 2024, the iconic Dow Jones Industrial Average, benchmark S&P 500, and grow
The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP
03:46am, Friday, 03'rd Jan 2025
Berkshire Hathaway, The Home Depot, Pfizer and AMREP are included in this Analyst Blog.
The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer
03:46am, Friday, 03'rd Jan 2025
Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer are included in this Analyst Blog.
Pfizer (PFE) Advances While Market Declines: Some Information for Investors
07:19pm, Thursday, 02'nd Jan 2025
In the latest trading session, Pfizer (PFE) closed at $26.61, marking a +0.3% move from the previous day.
Here's Why Pfizer (PFE) is a Strong Momentum Stock
11:07am, Thursday, 02'nd Jan 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
5 Large Drug Stocks to Keep An Eye On in the New Year
10:02am, Thursday, 02'nd Jan 2025
R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), AbbVie (ABBV), AstraZeneca (AZN) and Pfizer (PFE) are worth retain
Got $5,000? These 3 Stocks Are Absurdly Cheap Buys Heading Into 2025
07:30am, Thursday, 02'nd Jan 2025
The stock market enjoyed a strong year in 2024 as the S&P 500 hit new records. The challenge for investors looking to get into the market amid such a strong bull run, however, is that valuations for s
Top 3 Stocks Seeing a Spike in Call Option Volume
07:16am, Thursday, 02'nd Jan 2025
Volume is what drives the entire market, and that is a fact that often gets lost in the sea of indicators, patterns, and trend lines that dominate today's concept of analysis. However, most investors
Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics
07:00am, Thursday, 02'nd Jan 2025
Collaboration will leverage Atavistik Bio's proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two undisclosed, Pfizer-designated targets Atavistik Bio has
ChatGPT picks 5 undervalued stocks to watch at the start of 2025
10:15am, Wednesday, 01'st Jan 2025
Warren Buffett, one of the most famous investors of all time, made his billions with a getting rich slowly strategy and cleverly finding resilient and promising but undervalued businesses.
Pfizer's 2025 Comeback: What's Driving Growth
09:15am, Wednesday, 01'st Jan 2025
Pfizer targets $4 billion in operational savings by 2024, improving margins and driving long-term profitability. PFE returned $7.1 billion via dividends in 9M-24, while reducing debt by $4.4 billion t
Sangamo Therapeutics' stock falls the most in 16 years after Pfizer ends Hemophilia pact
11:22am, Tuesday, 31'st Dec 2024
The small-cap won't receive an expected payout in the first quarter, creating a cash overhang.
